Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia
Clinical trial NCT06759519 · COMPLETED
Trial details
- NCT number
- NCT06759519
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-30
- Primary completion
- 2025-09-19
- Enrollment
- 637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.